Hedge Fund - Cadian Capital

Blueprint Medicines Corp (BPMC) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2022 - Q4 (2022-12-31) $0 0% 0 $47.96
2 2022 - Q3 (2022-09-30) $96,162,000 5.62% 1,459,431 $64.23
3 2022 - Q2 (2022-06-30) $102,062,000 6.89% 2,020,629 $58.58
4 2022 - Q1 (2022-03-31) $122,736,000 6.12% 1,921,347 $71.78
5 2021 - Q4 (2021-12-31) $48,270,000 2.65% 450,657 $104.60
6 2021 - Q3 (2021-09-30) $108,177,000 4.08% 1,052,203 $93.12
7 2021 - Q2 (2021-06-30) $116,223,000 5.16% 1,321,313 $91.63
8 2021 - Q1 (2021-03-31) $88,839,000 3.28% 913,702 $99.84
9 2020 - Q4 (2020-12-31) $118,817,000 3.05% 1,059,450 $105.38
10 2020 - Q3 (2020-09-30) $249,072,000 8.1% 2,686,856 $77.01
11 2020 - Q2 (2020-06-30) $93,443,000 3.88% 1,197,989 $67.64
12 2020 - Q1 (2020-03-31) $71,702,000 3.52% 1,226,096 $64.35
13 2019 - Q4 (2019-12-31) $157,660,000 6.96% 1,968,038 $74.87
14 2019 - Q3 (2019-09-30) $104,232,000 4.95% 1,418,704 $86.44
15 2019 - Q2 (2019-06-30) $49,359,000 2.22% 523,261 $82.54
16 2019 - Q1 (2019-03-31) $16,010,000 0.62% 200,000 $73.89
17 2017 - Q4 (2017-12-31) $0 0% 0 $70.36
18 2017 - Q3 (2017-09-30) $21,874,000 1.02% 313,965 $53.44
19 2017 - Q2 (2017-06-30) $23,161,000 1.12% 457,102 $42.46
20 2017 - Q1 (2017-03-31) $6,994,000 0.33% 174,900 $35.81

The displayed share prices are average quarterly stock market prices.